AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
Lack of insulin-like growth factor I (IGF I) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers
Authors: Bakytny, R Jude, EB Gibson, JM Boulton, AJM Ferguson, MWJ
Citation: R. Bakytny et al., Lack of insulin-like growth factor I (IGF I) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers, J PATHOLOGY, 190(5), 2000, pp. 589-594
The diabetic foot
Authors: Jude, EB Boulton, AJM
Citation: Eb. Jude et Ajm. Boulton, The diabetic foot, DIABETES: CURRENT PERSPECTIVES, 2000, pp. 179-196
Consensus Development Conference on Diabetic Foot Wound Care - 7-8 April 1999, Boston, Massachusetts
Authors: Cavanagh, PR Buse, JB Frykberg, RG Gibbons, GW Lipsky, BA Pogach, L Reiber, GE Sheehan, P Apelqvist, J Armstrong, DG Boulton, AJM Caputo, GM Cianci, P Cohen, IK Falanga, V Foto, J Habershaw, GM Harding, KG Harkless, LB Krasner, D LoGerfo, FW Margolis, D Mayfield, JA Miller, SD Newman, L Olerud, J Ovington, LG Phillips, T Robson, MC Steed, DL Stromberg, K Ulbrecht, J Veves, A
Citation: Pr. Cavanagh et al., Consensus Development Conference on Diabetic Foot Wound Care - 7-8 April 1999, Boston, Massachusetts, J AM POD M, 89(9), 1999, pp. 475-483
Neuropathy and diabetes - Introduction
Authors: Boulton, AJM
Citation: Ajm. Boulton, Neuropathy and diabetes - Introduction, DIABET REV, 7(4), 1999, pp. 235-236
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy (Reprinted from Diabet Med, vol 15, pg 508-514, 1998)
Authors: Boulton, AJM Gries, FA Jervell, JA
Citation: Ajm. Boulton et al., Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy (Reprinted from Diabet Med, vol 15, pg 508-514, 1998), DIABET REV, 7(4), 1999, pp. 237-244
Current and emerging treatments for the diabetic neuropathies
Authors: Boulton, AJM
Citation: Ajm. Boulton, Current and emerging treatments for the diabetic neuropathies, DIABET REV, 7(4), 1999, pp. 379-386
End-stage complications of diabetic neuropathy
Authors: Jude, EB Boulton, AJM
Citation: Eb. Jude et Ajm. Boulton, End-stage complications of diabetic neuropathy, DIABET REV, 7(4), 1999, pp. 395-410
Study of 15636 patients found no influence of laterality on risk of amputation
Authors: Abbott, CA van Ross, ERE Kulkarni, J Shaw, JE Carrington, AL Boulton, AJM
Citation: Ca. Abbott et al., Study of 15636 patients found no influence of laterality on risk of amputation, BR MED J, 319(7205), 1999, pp. 318-319
Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic
Authors: Tentolouris, N Jude, EB Smirnof, I Knowles, EA Boulton, AJM
Citation: N. Tentolouris et al., Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic, DIABET MED, 16(9), 1999, pp. 767-771
A comparative study of the Podotrack, a simple semiquantitative plantar pressure measuring device, and the optical pedobarograph in the assessment ofpressures under the diabetic foot
Authors: van Schie, CHM Abbott, CA Vileikyte, L Shaw, JE Hollis, S Boulton, AJM
Citation: Chm. Van Schie et al., A comparative study of the Podotrack, a simple semiquantitative plantar pressure measuring device, and the optical pedobarograph in the assessment ofpressures under the diabetic foot, DIABET MED, 16(2), 1999, pp. 154-159
Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania - a prospective study
Authors: Dargis, V Pantelejeva, O Jonushaite, A Vileikyte, L Boulton, AJM
Citation: V. Dargis et al., Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania - a prospective study, DIABET CARE, 22(9), 1999, pp. 1428-1431
Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings
Authors: Reiber, GE Vileikyte, L Boyko, EJ del Aguila, M Smith, DG Lavery, LA Boulton, AJM
Citation: Ge. Reiber et al., Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings, DIABET CARE, 22(1), 1999, pp. 157-162
Trandolapril and human diabetic neuropathy - Reply
Authors: Malik, RA Heagerty, AM Boulton, AJM
Citation: Ra. Malik et al., Trandolapril and human diabetic neuropathy - Reply, LANCET, 353(9156), 1999, pp. 927-927
Structural abnormalities do not explain the early functional abnormalitiesin the peripheral nerves of the streptozotocin diabetic rat
Authors: Walker, D Carrington, A Cannan, SA Sawicki, D Sredy, J Boulton, AJM Malik, RA
Citation: D. Walker et al., Structural abnormalities do not explain the early functional abnormalitiesin the peripheral nerves of the streptozotocin diabetic rat, J ANAT, 195, 1999, pp. 419-427
The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1
Authors: Jude, EB Boulton, AJM Ferguson, MWJ Appleton, I
Citation: Eb. Jude et al., The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1, DIABETOLOG, 42(6), 1999, pp. 748-757
Perineurial abnormalities in the spontaneously diabetic dog
Authors: Ghani, M Malik, RA Walker, D Sharma, AK Lowrie, CT Schall, WD Boulton, AJM
Citation: M. Ghani et al., Perineurial abnormalities in the spontaneously diabetic dog, ACT NEUROP, 97(1), 1999, pp. 98-102
Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy.
Authors: Boulton, AJM
Citation: Ajm. Boulton, Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy., DIABETE MET, 24, 1998, pp. 55-65
Lowering the risk of neuropathy, foot ulcers and amputations
Authors: Boulton, AJM
Citation: Ajm. Boulton, Lowering the risk of neuropathy, foot ulcers and amputations, DIABET MED, 15(12), 1998, pp. S57-S59
Lowering the risk of neuropathy, foot ulcers and amputations
Authors: Boulton, AJM
Citation: Ajm. Boulton, Lowering the risk of neuropathy, foot ulcers and amputations, DIABET MED, 15(12), 1998, pp. S57-S59
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised doubleblind controlled trial
Authors: Malik, RA Williamson, S Abbott, C Carrington, AL Iqbal, J Schady, W Boulton, AJM
Citation: Ra. Malik et al., Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised doubleblind controlled trial, LANCET, 352(9145), 1998, pp. 1978-1981
Risultati: 1-25 | 26-45 |